Author

Julien Lannoy

Institut Pasteur

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Florence LarrousiD· 2 shared Guilherme Dias de MeloiD· 2 shared Hervé BourhyiD· 2 shared Lauriane KergoatiD· 2 shared Anthony ColéoniD· 1 shared David HardyiD· 1 shared Davide CortiiD· 1 shared Étienne KornobisiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Florence LarrousORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Host response against SARS-CoV-2 infection is impacted by allosteric modulation of cholinergic and purinergic receptors

Victoire Perraud, Guilherme Dias de Melo, Marco Cecchini, Lauriane Kergoat, Julien Lannoy, Jean‐Pierre Changeux, Hervé Bourhy, Florence Larrous

Ivermectin's protection in SARS-CoV-2-infected hamsters depended partly on both α7 nicotinic and P2X4 receptors; in co-cultures its effects were α7nAChR-independent, and P2X4 blockade prevented CXCL10 induction at 48 hpi.

bioRxiv · Oct 26, 2026 · PreprintPathology✦ In-depth digest

Monoclonal antibodies targeting the rabies virus glycoprotein promotes viral clearance and Fc-dependent neuroprotection in the infected brain

Seonhee Kim, Anthony Coléon, Florence Larrous, Lauriane Kergoat, Saïd Mougari, Julien Lannoy, Marta Simone Fabrício Tiago, David Hardy, Étienne Kornobis, Felix Augusto Rey, Fabio Benigni, Davide Corti, Hervé Bourhy, Guilherme Dias de Melo

This study evaluates monoclonal antibodies RVC20 and RVC58 for treating symptomatic rabies in mice, showing that intravenous and intramuscular administration can clear viral infection and improve survival, with RVC58 achieving 80% survival.

bioRxiv · Jun 16, 2026 · PreprintMicrobiology